Evidence map›Paper›PMID 33299017›Full record

ArticleScientific reports2020

Rapid microbial identification and colistin resistance detection via MALDI-TOF MS using a novel on-target extraction of membrane lipids.

Matthew Sorensen, Courtney E Chandler, Francesca M Gardner, Salma Ramadan, Prasanna D Khot, Lisa M Leung, Christine E Farrance, David R Goodlett, Robert K Ernst, Erik Nilsson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A critical role forProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Matthew SorensenPataigin, LLC, Seattle, WA, USA. matthew@pataigin.com.
Courtney E ChandlerPataigin, LLC, Seattle, WA, USA.
Francesca M GardnerPataigin, LLC, Seattle, WA, USA.
Salma RamadanPataigin, LLC, Seattle, WA, USA.
Prasanna D KhotCharles River Laboratories, Inc., Newark, DE, 19711, USA.
Lisa M LeungMaryland Department of Health and Mental Hygiene, Baltimore, MD, 21205, USA.
Christine E FarranceCharles River Laboratories, Inc., Newark, DE, 19711, USA.
David R GoodlettUniversity of Maryland, Baltimore, Baltimore, MD, 21201, USA.
Robert K ErnstUniversity of Maryland, Baltimore, Baltimore, MD, 21201, USA. Rkernst@umaryland.edu.
Erik NilssonPataigin, LLC, Seattle, WA, USA.
University of Maryland, Baltimore · USVashon Partners (United States) · USCharles River Laboratories (United States) · USUnited States Food and Drug Administration · US

Funding

Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2M
MS Diagnostic Bacterial Identification LibraryR01AI147314 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, GOODLETT, DAVID ROBINSON · 2020 to 2024
$2.3M
MS diagnostic bacterial identification libraryR01GM111066 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, GOODLETT, DAVID ROBINSON · 2014 to 2017
$1.2M
NIAID NIH HHS R01 AI104895NIAID NIH HHS R01 AI147314NIGMS NIH HHS R01 GM111066NIGMS NIH HHS R01GM111066
6 · The paper itself

Abstract

Rapid infection diagnosis is critical to improving patient treatment and outcome. Recent studies have shown microbial lipids to be sensitive and selective biomarkers for identifying bacterial and fungal species and antimicrobial resistance. Practical procedures for microbial lipid biomarker analysis will therefore improve patient outcomes and antimicrobial stewardship. However, current lipid extraction methods require significant hands-on time and are thus not suited for direct adoption as a clinical assay for microbial identification. Here, we have developed a method for lipid extraction directly on the surface of stainless-steel matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) plates, termed fast lipid analysis technique or FLAT, which facilitates the identification of bacterial and fungal species using a sub-60-minute workflow. Additionally, our method detects lipid A modifications in Gram-negative bacteria that are associated with antimicrobial resistance, including to colistin.

Indexed as

ColistinDrug Resistance, BacterialGram-Negative BacteriaGram-Positive BacteriaSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBiomarkersLipidsBiomarkersColistinLipids

Identifiers

PMID33299017
PMCPMC7725828
OpenAlexW3111179909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.